← 返回每日简报
Antibodies · 抗体药物
抗体类免疫治疗在器官移植中的应用 · 共 15 条资讯 · 每日更新 · 按时间倒序
📰 行业资讯 2025-11-14 · Frontiers
Editorial: Finding new hope in old treatments: repurposing immunotherapy in transplantation - Frontiers
📰 行业资讯 2025-09-12 · RegMedNet
CHAR-Tregs: a potential approach for reducing risk of transplant rejection - RegMedNet
📰 行业资讯 2025-09-09 · Memorial Sloan Kettering Cancer Center
Improved Urothelial Carcinoma Prognosis With Antibody-Drug Conjugate Treatment - Memorial Sloan Kettering Cancer Center
📰 行业资讯 2025-08-25 · Frontiers
Editorial: Repurposing cancer immunotherapies for use in autoimmunity and transplantation - Frontiers
📰 行业资讯 2025-02-26 · National Cancer Institute (.gov)
CAR T Cells: Engineering Patients’ Immune Cells to Treat Their Cancers - National Cancer Institute (.gov)
📰 行业资讯 2024-04-02 · Mayo Clinic News Network
Could CAR-T cell therapy improve kidney transplants? - Mayo Clinic News Network
📰 行业资讯 2024-02-09 · Frontiers
Modulatory immune responses in fungal infection associated with organ transplant - advancements, management, and challenges - Frontiers
📰 行业资讯 2023-08-18 · Nature
Immunotherapy in hematologic malignancies: achievements, challenges and future prospects - Nature
📰 行业资讯 2023-04-17 · Fred Hutchinson Cancer Center
Work smarter not harder: Leveraging cancer immunotherapies to improve organ transplantation - Fred Hutchinson Cancer Center
📰 行业资讯 2023-02-16 · Fred Hutchinson Cancer Center
How blood cancer research might help organ transplant patients - Fred Hutchinson Cancer Center
📰 行业资讯 2023-01-02 · UC San Francisco
Duping Antibodies with a Decoy, Researchers Aim to Prevent Rejection of Transplanted Cells - UC San Francisco
📰 行业资讯 2022-12-12 · Wiley Online Library
Allograft rejection following immune checkpoint inhibitors in solid organ transplant recipients: A safety analysis from a literature review and a pharmacovigilance system - Wiley Online Library
📰 行业资讯 2022-03-18 · Bristol Myers Squibb (BMS)
U.S. Food and Drug Administration Approves First LAG-3-Blocking Antibody Combination, Opdualag™ (nivolumab and relatlimab-rmbw), as Treatment for Patients with Unresectable or Metastatic Melanoma - Bristol Myers Squibb (BMS)
📰 行业资讯 2021-12-27 · Newswise
Penn Medicine Awarded $14 Million NIH Grant to Apply CAR T Immunotherapies to Match More Patients in Need of Kidney Transplants | Newswise - Newswise
📰 行业资讯 2021-11-10 · WashU Medicine
New technique may lead to safer stem cell transplants - WashU Medicine